Ergenç, İ. Et Al. 2023. RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.3 , 310.

Ergenç, İ., KANİ, H. T., KARABACAK, M., CÖMERT ÖZER, E., Mehdiyev, S., Jafarov, F., ... ABACAR, K. Y.(2023). RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.3, 310.

Ergenç, İlkay Et Al. "RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy," The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.3, 310, 2023

Ergenç, İlkay Et Al. "RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy." The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.3, pp.310, 2023

Ergenç, İ. Et Al. (2023) . "RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy." The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.3, p.310.

@article{article, author={İlkay Ergenç Et Al. }, title={RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy}, journal={The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology}, year=2023, pages={310} }